&0183;&32;In September, Athira Pharma completed its IPO of 12,000,000 shares of common stock at a public offering price of . A brief summary - strong Buy, Buy, strong Sell, Sell or Neutral signals for the Athira Pharma Inc stock. (See Athira Pharma stock analysis on TipRanks) Denali Therapeutics (DNLI) Dedicated to defeating neurodegenerative diseases through rigorous therapeutic development, Denali Therapeutics is attracting significant attention from Wall Street. (ATHA) Stock Guide.
Symbol Last Price; Stocks: Most Actives. The Schedule 13D indicates that the investor holds (or held) more than 5% of the company and intends (or intended) to. Shares of Athira Pharma, Inc.
The stock traded as high as . The ATHA stock price is -33. ATHA has been the subject of a.
Get Athira Pharma Inc (ATHA:NASDAQ) real-time stock quotes, news and financial information from CNBC. 4% above the IPO price. stock was issued. Athira Pharma (ATHA) has been awarded a research grant expected to total M over 3 years from the National Institute on Aging of the National Institutes of Health ((NIH)) to support its Phase 2 ACT-AD trial for ATH-1017, Athira’s lead candidate being developed for mild-to-moderate Alzheimer's disease.
rallied in their public debut, as the first trade was 17. 93% from its latest closing price compared to the recent 1-year high of . ATHA Ideas on StockTwits; ATHA Tweets on Twitter ; Indicators Indicator Value. Turn on notifications for this stock. (ATHA) stock quote, history, news and other vital information to help you with your stock trading and investing. Notable SEC filings of Athira Pharma, Inc. Die Psychedelischen Aktien von Athira Pharma Inc. 0 million before deducting underwriting discounts and commissions and estimated offering expenses.
94% above the 52-week low of . (NASDAQ:ATHA) hit a new 52-week high during trading on Friday. ATHIRA PHARMA, INC. Neue Boombranche Nr 1.
The stock had previously closed at . News impact on Athira Pharma, Inc. If you're looking for a quick athira pharma stock scoop on ATHA stock (chart, price target, market cap, news and buy or sell. Seattle-based Athira Pharma, a late clinical-stage biopharmaceutical company, has raised 4 million for its IPO after pricing its 12 million shares at per share. HOME MARKET TRADE PRICING DOWNLOAD HELP. The company traded as high as . A number of equities research analysts recently commented on the company.
case arguments for now! (NASDAQ:ATHA)’s traded shares stood at 306,411 during the last session, with the company’s beta value hitting 0. 00%--Athira Pharma nabs research grant of M from NIH.
14, (GLOBE NEWSWIRE) -- Athira Pharma, Inc. and hear what the experts at. Webull offers ATHA stock news, real time Athira athira pharma stock Pharma, Inc. Stocks close lower, notching third straight weekly loss as tech-led sell-off intensifies MarketWatch. Symbol Last Price; Currencies. ATHA, priced its initial public offering at a. 06% of gains in the last five trading sessions. Athira Pharma Announces Closing of Initial Public Offering: Sep 22: The Daily Biotech Pulse: Legal Relief For Evolus, Fulgent to Join S&P SmallCap 600, AIM ImmunoTech's Positive Cancer Drug Readout: Sep 18: Athira Pharma's stock jumps at its open, with the first trade 17% above the IPO price: See more ATHA news.
Go add some tickers to it! (NASDAQ:ATHA) rose 5. Mark Litton to Board of Directors. Condensed Consolidated Balance Sheets (Unaudited) (Amounts in thousands) September 30, Decem Assets Cash and cash equivalents 5,725 ,056 Short-term investments 60,547 0 Other short-term assets 5,994 104.
Your list is empty. Get the hottest stocks to trade every day before. As the company gears up to report first proof-of-concept biomarker data for DNL310 in Hunter. The company, currently valued at 4. 50 and last traded at . ” Goldman Sachs, Jefferies and Stifel are the lead underwriters. A detailed technical analysis through moving averages buy/sell signals (simple and.
Vor 2 Tagen &0183;&32;SEATTLE, Dec. The company traded as high as . In October, Athira sold an additional 1,397,712 shares of common stock to the underwriters of the IPO upon. Find real-time ATHA - Athira Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. View detailed financial information, real-time news, videos, quotes and analysis on Athira Pharma, Inc. Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating Performance.
Athira Pharma's stock jumps at its open, with the first trade 17% above the IPO price. (NASDAQ:ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to. Athira Pharma nabs research grant of M from NIH. Discover historical prices for ATHA stock on Yahoo Finance. View daily, weekly or monthly formats back to when Athira Pharma, Inc. The stock had previously closed at .
All other trademarks belong to their respective owner. ATHA historical stock prices, in-depth market analysis, NASDAQ:ATHA real-time stock quote data, in-depth charts, and a fully built financial calendar to help you invest smart. Find the latest Athira Pharma, Inc. Given the potential of its asset athira pharma stock in Alzheimer’s disease (AD), Goldman Sachs is pounding the table. 92%) As of 3:25PM EST. Before we start: if you're looking for ATHA stock price, you can quickly find it out by visiting Finny and typing "ATHA quote". &0183;&32;Stock quote and company snapshot for ATHIRA PHARMA INC (ATHA), including profile, stock chart, recent news and events, analyst opinions, and research reports. Registered Shares DL -,0001.
(NASDAQ:ATHA)’s stock price hit a new 52-week high during mid-day trading on Wednesday. Athira Pharma Aktie (ATHA) mit Realtime-Aktienkurs, Chart, Bilanzinformationen, Dividenden, historischen Daten, aktuellen News und Analysen. The ATHA share’s 52. (ATHA) Add to watchlist. &0183;&32;Athira’s common stock is expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “ATHA” on Septem.
Symbol Last Price; Trending Tickers. At the close of trading, the stock’s price was . Athira Pharma, Inc. Press Release reported on 10/08/20 that Lumen Bioscience Announces Appointment of Dr. 22 per share which meant it lost -.
Explore commentary on Athira Pharma, Inc. Athira Pharma started at buy with stock price target at Stifel Nicolaus MarketWatch. The stock began trading Septem on the NASDAQ under the ticker symbol “ATHA. Symbol Last Price; Stocks: Gainers. 48% rallied in their public debut, as the first trade was 17. : Kurs, Charts, Kurse, Empfehlungen, Fundamentaldaten, Echtzeitnews athira pharma stock und Analysen der athira pharma stock Aktie ATHIRA PHARMA, INC. ATHA made its public market debut on September 18, with the first trade coming in at 17. The study will use quantitative.
Filings by Transaction Date; Filings by. In addition, Athira has granted the underwriters a 30-day option. Loading interactive chart. Athira Pharma's stock jumps at its open, with the first trade 17% above the IPO price marketwatch. Your watchlist is empty.
About Athira Pharma, Inc. Athira athira pharma stock Pharma Inc (OQ:ATHA) Business Focus: Biotechnology & Medical Research. &0183;&32;WELCOME TO THE STOCKGURU TEAM! Approximately 503,156 shares were traded during mid-day trading, an increase of 79% from the average daily volume of 280,467 shares. news help you invest smart. (NASDAQ:ATHA) has a beta value of 0 and has seen 423,188 shares traded in the last trading session. Entity Central Index Key:: Entity Current Reporting Status: No : Entity Interactive Data Current: Yes : Current Fiscal Year End Date--12-31 : Entity Filer Category: Non-accelerated Filer : Entity Common Stock, Shares Outstanding : 32,485,184: Entity Shell Company: false : Entity Small Business: true : Entity Emerging Growth Company: true : Entity Ex Transition.
Neuer Psychedelischer Aktientip nach 654% mit Numinus Wellness (LKYSF) und 1. is a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration. &0183;&32;Athira’s common stock began trading on the Nasdaq Global Select Market under the ticker symbol “ATHA” on Septem. 81 Million, closed the last trade at . (NASDAQ:ATHA) went up by 13.
Major shareholders can athira pharma stock include individual investors, mutual funds, hedge funds, or institutions. Vor 1 Tag &0183;&32;Unser Psychedelic Hot Stock Better Life Pharma Inc. All filings Filter. 4% above the initial public offering price. NasdaqGS - NasdaqGS Real Time Price.
87, with a volume of 356 shares changing hands. The company’s stock price has collected 22. Read market forecasts, ATHA financials, economic background and market news. We are here to help you succeed in everything you do and although this is a journey you are taking the first step towards success and we at StockGuru thank you for your continued support.
Turn off notifications for this stock. Raising 4 million, the. Get updated prices on the option chain for Athira Pharma Inc. &0183;&32;Athira Pharma, Inc.
98 in intraday trading. INK Ultra Money Free. Friday, Septem.
Applying cutting-edge approaches to neurodegenerative diseases, Athira Pharma wants to improve the lives of patients from all over the world. Athira Pharma prices upsized IPO at , high end of price range Filter news. Athira Pharma Inc Ordinary Shares ATHA Morningstar Rating Rating athira pharma stock as of. Psychedelic Hot Stock meldet spektakul&228;re &220;bernahme.
52 and last traded at . View ATHA call options and athira put options by expiry date. 8-K : Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits 10-Q.
Athira’s pre-IPO backers included Perceptive Advisors. Massives Kaufsignal. Athira Pharma's stock jumps at its open, with. 091% mit Mind Medicine (MMEDF) - AC Research 27 and last traded at . Athira Pharma's stock jumps at its open, with the first trade 17% above the IPO price By MarketWatch - Shares of Athira Pharma Inc.
41, to imply an increase of 3. (US:ATHA) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Athira Pharma (ATHA) has been awarded a research grant expected to total M over 3 years from the National Institute on Aging of the National Institutes of. 00 per share, generating gross proceeds of 4. comAthira Pharma, Inc. ATHA has been the topic of a number of research reports.
35, with a volume of 3829 shares changing hands. View Athira Pharma Inc price, streaming chart and supplemental info. (ISIN CA08772P / WKN A2P7XN, Ticker: NPAU,. Athira Pharma's stock pulls back after the open, trades briefly below IPO price MarketWatch. Symbol Last Price. Shares of Athira Pharma Inc. INK Ultra Money Videos. Athira, headquartered in Seattle, Washington, is a drug development company striving to improve human health by advancing new therapies for neurodegenerative diseases.
Investor & Media Contact: Julie Rathbun Athira Pharma Julie. The stock had previously closed at . &0183;&32;Athira Pharma Inc. Insider Overview ; Charts ; Valuations; News ; Biz Brief; Get holdings trends & enhanced insider charts in PDF now ; Show only public market trades. Athira Pharma prices upsized IPO at , high end of price range. The Company’s pipeline is built from its drug discovery platform (ATH) platform, and consists of a series of small molecules that are designed to target either the central nervous system (CNS), by crossing the blood brain barrier (BBB. Ahead of a key data readout, Goldman Sachs has high hopes.
51 on the day or -2. Athira Pharma Inc. 24% during that session. Webull offers Athira Pharma, Inc. 71% off its 52-week high price of . Market Watch - 1 month ago./50613/7450 /712/9f7c4fd8.shtml /22724-164 /59962.pl /b307259606b1b.aspx /9c6646d065cd7-986 /49424/a5c7a8b169.shtml /3a4d043e09b/984 /145272b86187d2.shtml /41541.aspx
-> South state bank stock price
-> Lifetime fitness stock